K. Bajou

发表

Emerging roles for proteinases in cancer.

L. Devy, J. Foidart, A. Noël, 1997, Invasion & metastasis.

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

P. Carmeliet, J. Foidart, A. Gils, 2004, Oncogene.

Rosiglitazone Enhances Browning Adipocytes in Association with MAPK and PI3-K Pathways During the Differentiation of Telomerase-Transformed Mesenchymal Stromal Cells into Adipocytes

A. A. Khan, S. Abdallah, K. Bajou, 2019, International journal of molecular sciences.

Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.

P. Carmeliet, J. Foidart, C. Munaut, 2005, Neoplasia.

Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.

J. Rakic, V. Lambert, P. Carmeliet, 2003, Investigative ophthalmology & visual science.

Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis.

J. Foidart, J. Martial, Y. DeClerck, 2008, Cancer cell.

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin

P. Carmeliet, J. Foidart, A. Noël, 2001, The Journal of cell biology.

Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro.

J. Foidart, A. Noël, M. Mareel, 1997, Experimental cell research.

Regulation of cancer invasion and vascularization by plasminogen activator inhibitor-1

J. Rakic, V. Lambert, L. Devy, 1999 .

Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells.

L. Devy, J. Foidart, A. Noël, 1997, Biochemical and biophysical research communications.

Molecular interactions involving urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor, plasminogen activator inhibitor-1 (PAI-1), as new targets for tumour therapy

J. Foidart, A. Noël, C. Munaut, 1999 .

The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis

P. Carmeliet, J. Martial, S. Herkenne, 2015, Science Signaling.

PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin

P. Carmeliet, J. Martial, A. Gils, 2014, Nature Medicine.

Interactions between endothelial cells and smooth muscle cells after their activation by hypoxia. A possible etiology for venous disease.

J. Remacle, T. Arnould, C. Michiels, 1996, International angiology : a journal of the International Union of Angiology.

New functions of stromal proteases and their inhibitors in tumor progression.

L. Devy, J. Foidart, A. Noël, 2001, Surgical oncology clinics of North America.

Involvement of PA/plasmin system in the processing of pro‐MMP‐9 and in the second step of pro‐MMP‐2 activation

J. Foidart, A. Noël, H. Krell, 1997, FEBS letters.

The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

L. Devy, P. Carmeliet, J. Foidart, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin

Nils Brünner, Robert D. Gerard, Geert Carmeliet, 2001, The Journal of cell biology.

Mouse Aortic Ring Assay: A New Approach of the Molecular Genetics of Angiogenesis

L. Devy, P. Carmeliet, J. Foidart, 2002, Biological Procedures Online.

Contribution of host MMP‐2 and MMP‐9 to promote tumor vascularization and invasion of malignant keratinocytes

S. Itohara, J. Foidart, A. Noël, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

M. Skobe, P. Carmeliet, J. Foidart, 1998, Nature Medicine.

Endothelial cell intracellular Ca concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration

J. Foidart, D. Cataldo, C. Lambert, 2004, Clinical & Experimental Metastasis.

Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.

J. Rakic, V. Lambert, P. Carmeliet, 2007, The American journal of pathology.

The antitumoral effect of endostatin and angiostatin is associated with a down‐regulation of vascular endothelial growth factor expression in tumor cells

L. Devy, J. Foidart, S. Blacher, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The Plasminogen–Activator Plasmin System in Physiological and Pathophysiological Angiogenesis

K. Bajou, A. A. Ismail, Baraah Tariq Shaker, 2021, International journal of molecular sciences.

Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA‐PAI‐1 and by enhancing their expression

J. Foidart, A. Noël, C. Soria, 2002, International journal of cancer.

DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase

Maud Martin, F. Dequiedt, T. Mustelin, 2014, Molecular Cancer.

Role of plasminogen activator-plasmin system in tumor angiogenesis

J. Rakic, V. Lambert, L. Devy, 2003, Cellular and Molecular Life Sciences CMLS.

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization.

J. Rakic, V. Lambert, P. Carmeliet, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

J. Rakic, V. Lambert, P. Carmeliet, 2001 .

The 14-Kilodalton Human Growth Hormone Fragment a Potent Inhibitor of Angiogenesis and Tumor Metastasis

M. Rahmani, I. Struman, K. Bajou, 2023, International journal of molecular sciences.